scholarly journals Differential Diagnosis for Female Pelvic Masses

10.5772/53139 ◽  
2013 ◽  
Author(s):  
Francesco Alessandrino ◽  
Carolina Dellafiore ◽  
Esmeralda Eshja ◽  
Francesco Alfano ◽  
Giorgia Ricci ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Pelvic Masses

Non-Gynecologic Causes of Adnexal/Pelvic Masses

2018 ◽  
Vol 15 (1) ◽  
pp. 46-49
Author(s):  
Michelle L. Gainty ◽  
Christina Jones
Keyword(s):  
Differential Diagnosis ◽  
Female Patient ◽  
Diagnostic Dilemma ◽  
Adnexal Masses ◽  
Pelvic Masses

Pelvic masses can pose a diagnostic dilemma with a broad differential to include both gynecological and non-gynecologic etiologies. While the initial instinct may be to search for gynecologic causes for the female patient, non-gynecologic etiologies must be considered as well. The presentation can be similar amongst many different causes of pelvic masses and imaging is generally required for further assessment to determine if the mass is intra- or extraperitoneal. The etiology of adnexal masses covers several subspecialties: gynecology, urology, gastroenterology, neurology, and oncology. For this reason, it is important for all to be aware of the differential diagnosis for pelvic masses.

Pelvic echinococcosis in differential diagnosis of pelvic masses

2006 ◽  
Vol 129 (1) ◽  
pp. 98-99 ◽  
Author(s):  
Tugrul Aydogdu ◽  
Tayfun Gungor ◽  
Mengu Tug ◽  
Sabri Cavkaytar
Keyword(s):  
Differential Diagnosis ◽  
Pelvic Masses

scholarly journals Differential Diagnosis of Tubal Hydatid Cyst in the Pelvic Masses

2018 ◽  
Author(s):  
Adnan Budak ◽  
Aykut Özcan ◽  
Tuğba Karadeniz ◽  
Ramazan Güven ◽  
Muzaffer Sancı
Keyword(s):  
Differential Diagnosis ◽  
Hydatid Cyst ◽  
Pelvic Masses

A Prospective Study of Tc-99m MIBI in the Differential Diagnosis of Pelvic Masses in Female Patients

2000 ◽  
Vol 25 (8) ◽  
pp. 614-618 ◽  
Author(s):  
JIAHE TIAN ◽  
JINMING ZHANG ◽  
LUXIA JIAO ◽  
YALI LI ◽  
LIMIN CAO
Keyword(s):  
Differential Diagnosis ◽  
Prospective Study ◽  
Female Patients ◽  
Pelvic Masses ◽  
A Prospective Study

Differential diagnosis of pelvic masses by gray scale sonography

1978 ◽  
Vol 131 (3) ◽  
pp. 469-476 ◽  
Author(s):  
AC Fleischer ◽  
AE James ◽  
JB Millis ◽  
C Julian
Keyword(s):  
Differential Diagnosis ◽  
Gray Scale ◽  
Pelvic Masses

scholarly journals Hydatidosis of the Pelvic Cavity: A Big Masquerade

2008 ◽  
Vol 2008 ◽  
pp. 1-3 ◽  
Author(s):  
Peyman Varedi ◽  
Seyed Reza Saadat Mostafavi ◽  
Rambod Salouti ◽  
Daryoush Saedi ◽  
Seyed Ali Nabavizadeh ◽  
...  
Keyword(s):  
Weight Loss ◽  
Differential Diagnosis ◽  
Abdominal Pain ◽  
Hydatid Cyst ◽  
Unusual Presentation ◽  
Pelvic Cavity ◽  
Surgical Exploration ◽  
Pelvic Masses ◽  
Microscopic Studies ◽  
Primary Hydatid Cyst

We report and discuss a case of primary hydatidosis of the pelvic cavity in a woman who presented with severe weight loss and abdominal pain. This unusual presentation was initially considered as a tumor process until surgical exploration and microscopic studies confirmed the diagnosis. The gynecologists should be aware of possibility of primary hydatid cyst of the pelvic cavity and should be considered in the differential diagnosis of cystic pelvic masses, especially in areas where the disease is endemic.

MRI of Recurrent Cystic Mesothelioma: Differential Diagnosis of Cystic Pelvic Masses

1994 ◽  
Vol 54 (3) ◽  
pp. 377-380 ◽  
Author(s):  
Javier A. Romero ◽  
E.Edmund Kim ◽  
Andrzej P. Kudelka ◽  
Creighton L. Edwards ◽  
John J. Kavanagh
Keyword(s):  
Differential Diagnosis ◽  
Pelvic Masses ◽  
Cystic Mesothelioma

Pelvic “lipolymph nodes”: A consideration in the differential diagnosis of pelvic masses

1980 ◽  
Vol 136 (6) ◽  
pp. 727-731 ◽  
Author(s):  
Javier F. Magrina ◽  
Richard E. Symmonds ◽  
David C. Dahlin
Keyword(s):  
Differential Diagnosis ◽  
Pelvic Masses

Evaluation of Proteomics-Identified CCL18 and CXCL1 as Circulating Tumor Markers for Differential Diagnosis between Ovarian Carcinomas and Benign Pelvic Masses

2011 ◽  
Vol 26 (4) ◽  
pp. 262-273 ◽  
Author(s):  
Qi Wang ◽  
Danrong Li ◽  
Wei Zhang ◽  
Bujian Tang ◽  
Qingdi Quentin Li ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Differential Diagnosis ◽  
Tumor Markers ◽  
Laser Desorption ◽  
Ca 125 ◽  
Laser Desorption Ionization ◽  
Desorption Ionization ◽  
Healthy Women ◽  
Pelvic Masses ◽  
Ovarian Masses

A lack of sensitive and specific tumor markers for early diagnosis and treatment is a major cause for the high mortality rate of ovarian cancer. The purpose of this study was to identify potential proteomics-based biomarkers useful for the differential diagnosis between ovarian cancer and benign pelvic masses. Serum samples from 41 patients with ovarian cancer, 32 patients with benign pelvic masses, and 41 healthy female blood donors were examined, and proteomic profiling of the samples was assessed by surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectroscopy (MS). A confirmatory study was also conducted with serum specimens from 58 patients with ovarian carcinoma, 37 patients with benign pelvic masses, and 48 healthy women. A classification tree was established using Biomarker Pattern Software. Six differentially expressed proteins (APP, CA 125, CCL18, CXCL1, IL-8, and ITIH4) were separated by high-performance liquid chromatography and identified by matrix-assisted laser desorption/ionization (MALDI)-MS/MS and database searches. Two of the proteins overexpressed in ovarian cancer patients, chemokine CC2 motif ligand 18 (CCL18) and chemokine CXC motif ligand 1 (CXCL1), were automatically selected in a multivariate predictive model. These two protein biomarkers were then validated and evaluated by enzyme-linked immunosorbent assay (ELISA) in 535 serum specimens (130 ovarian cancer, 64 benign ovarian masses, 36 lung cancer, 60 gastric cancer, 55 nasopharyngeal carcinoma, 48 hepatocellular carcinoma, and 142 healthy women). The combined use of CCL18 and CXCL1 as biomarkers for ovarian cancer had a sensitivity of 92% and a specificity of 97%. The multivariate ELISA analysis of the two putative markers in combination with CA 125 resulted in a sensitivity of 99% for healthy women and 94% for benign pelvic masses, and a specificity of 92% for both groups; these values were significantly higher than those obtained with CA 125 alone (P<0.05). We conclude that serum CCL18 and CXCL1 are potentially useful as novel circulating tumor markers for the differential diagnosis between ovarian cancer and benign ovarian masses.

Sign in / Sign up

Export Citation Format

Share Document